Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Cole

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Neuron|April 3, 2003
Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases?Greg M Cole
Molecular Neurobiology|May 4, 2010
Why pleiotropic interventions are needed for Alzheimer's diseaseSally A Frautschy, Greg M Cole
The Journal of Nutrition|February 26, 2010
DHA may prevent age-related dementiaGreg M Cole, Sally A Frautschy
Alzheimer'S Research & Therapy|January 22, 2011
What was lost in translation in the DHA trial is whom you should intend to treatSally A Frautschy, Greg M Cole
Trends in Molecular Medicine|August 2, 2006
Alzheimer's amyloid story finds its starGreg M Cole, Sally A Frautschy
Neuron|September 20, 2006
Cat and mouseGreg M Cole, Sally A Frautschy
Nutrition and Health|December 22, 2006
Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse modelGreg M Cole, Sally A Frautschy
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." Pleiotropic approaches to Alzheimer's and other diseases of agingGreg M Cole, Sally A Frautschy
Experimental Gerontology|October 20, 2006
The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's DiseaseGreg M Cole, Sally A Frautschy
CNS & Neurological Disorders Drug Targets|March 9, 2010
Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's diseaseGreg M Cole, Sally A Frautschy
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Neuron|April 3, 2003
Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases?Greg M Cole
Molecular Neurobiology|May 4, 2010
Why pleiotropic interventions are needed for Alzheimer's diseaseSally A Frautschy, Greg M Cole
The Journal of Nutrition|February 26, 2010
DHA may prevent age-related dementiaGreg M Cole, Sally A Frautschy
Alzheimer'S Research & Therapy|January 22, 2011
What was lost in translation in the DHA trial is whom you should intend to treatSally A Frautschy, Greg M Cole
Trends in Molecular Medicine|August 2, 2006
Alzheimer's amyloid story finds its starGreg M Cole, Sally A Frautschy
Neuron|September 20, 2006
Cat and mouseGreg M Cole, Sally A Frautschy
Nutrition and Health|December 22, 2006
Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse modelGreg M Cole, Sally A Frautschy
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Commentary on "Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery." Pleiotropic approaches to Alzheimer's and other diseases of agingGreg M Cole, Sally A Frautschy
Experimental Gerontology|October 20, 2006
The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's DiseaseGreg M Cole, Sally A Frautschy
CNS & Neurological Disorders Drug Targets|March 9, 2010
Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's diseaseGreg M Cole, Sally A Frautschy
Pageof 5